Translating encouraging preliminary results of novel immuno-gene therapy, in combination with a novel molecular genetic chemotherapy, into a new treatment for intracerebral breast cancer. 2003 NeuroGrant Recipient

Translating encouraging preliminary results of novel molecular genetic immunotherapy into the clinical setting. Determining the safety and efficacy of treating human intracerebral malignant tumors using genetically modified IL-2 secreting cells as a tumor vaccine.

Formation of a Pituitary Patient Support Group to serve as a clearinghouse of information for treatment options, as well as a source of support for those dealing with the emotional aspects of such illnesses. 2004 NeuroGrant Recipient

Determine the safety and efficacy of treating human intracerebral malignant tumors using genetically modified IL-2 secreting cells transduced with the patient’s DNA, as a tumor vaccine. 2006 NeuroGrant Recipient

To investigate the influence that both state and trait anxiety has on physiological markers of stress and to subsequent post-surgical related outcomes. 2006 NeuroGrant Recipient

White paper funded by generous grants from HER2 Support Group and Elekta Inc. describing the treatment options for patients with metastatic breast cancer.

An educational symposium to help ensure allied health professionals are fully educated as to the signs, symptoms and treatment options available for back and neck pain. 2006 NeuroGrant Recipient

Evaluate the role of pro-inflammatory and anti-inflammatory cytokines in OMS; to determine the effects of immunotherapy on the cytokine profile; an correlate cytokine abnormalities with clinical variables such as disease severity. 2006 NeuroGrant Recipient

To determine the expression of chemokine receptors for on the immune cell type the chemokine recruits to inflamed brain. 2007 NeuroGrant Recipient

To provide newly diagnosed brain tumor patients an opportunity to speak with a health care coordinator 7 and 20 day post-discharge. They will be asked questions designed to quickly assess their functioning that will dovetail with an assessment tool provided at discharge which will enable patients to identify and communicate subtle changes in their functioning that will allow for patient centered solutions. 2007 NeuroGrant Recipient

Determining if the Placing Test can be used to screen brain tumor patients for complications or regrowth. 2003 NeuroGrant Recipient